High Profile CEO Life Sciences Delegation From Austria Announce Their Visit To America.
Chief Executive Officers representing eight flagship Medical Technology companies from Austria will visit Minneapolis and New Jersey during a one-week trip (December 5-9, 2011) to engage in a busy and substantive business development meetings program
Online, October 18, 2011 (Newswire.com) - Chief Executive Officers (CEOs) representing eight flagship Medical Technology companies from Austria will visit Minneapolis and New Jersey during a one-week trip (December 5-9, 2011) to engage in a busy and substantive program designed to stimulate collaborations with US medical technology and other life science companies located in Minnesota and New Jersey.
This program is supported by ADVANTAGE AUSTRIA, the official Austrian Foreign Trade Promotion Organisation and the largest provider of services in the area of foreign trade. The program is designed and operated by MedNest, a US-based enterprise and developer of innovative medical technology companies.
"Biotechnology, Medical Technology and Life Sciences are among the key technologies of the 21st century. In Austria, the existing networks of established Medical Technology companies, dynamic young biotechnology firms, leading research institutes and universities, as well as important clusters, provide the ideal springboard for a successful future. This program will generate growth prospect for the all the participating companies and reinforce the already strong relationship between the US and our Country", says Christian Kesberg, Trade Commissioner of Austria in the US.
The program offered to the delegation includes several workshops to address key challenges of introducing Medical Technologies to the US markets, ranging from clinical and economic evaluation of these technologies to possible business models for foreign companies to create a footprint in the USA. Regulatory (FDA) discussion is regularly included in the program.
"This is the fourth and 2011 edition of this Transatlantic Economic Development program, and the compounded economic impact for the US ecosystems is poised to be significant in the coming 2-3 years" says Mathieu Petitjean, Ph.D., CEO of MedNest.
During the program, CEOs will be exposed to multiple targeted business development and technology partnership opportunities with several US companies. All the companies will participate to the 1-th Annual Life Science Alley Conference & Expo (Dec 5th 2011, Minneapolis), a high profile MedTech industry event, with more than 200 organizations represented in the Exhibit Hall and a strong Conference Program.
The eight companies from Austria are in the following technologies and markets:
•Diagnostics kits to facilitate quantitative metabolite and biomarker analysis, including panels for Sterols, for Chronic Kidney Disease and Diabetic Nephropathy
•Non-invasive patient cooling devices to increase survival rates from a cardiac arrest
•Mouth-activated Wireless Computer mouse for severely disabled people
•Photonic Tumor Therapy
•Portable sterile air laminar flow unit to enhance contamination control at "point-of-surgery"
•Training and rehabilitation equipment dedicated to balance conditions, neurophysiologic rehabilitation, sport, and fall prevention.
•Point-of-use and plug-and-play fall detection system, fully integrated with home monitoring.
•Contract Medical Device Development and Manufacturing services with core expertise in Opto-mecatronics.
Companies interested in connecting with the CEOs form this Austrian Delegation are invited to reach out to Advantage Austria (www.austria.info/us) or MedNest (www.mednest.com).